CATAFLY SYRUP 140 ML
diclofenac potassium, anti inflammatory agents .
ACTIVE-INGREDIENT OF CATAFLY SYRUP 140 ML
each 1 ml of catafly oral suspension contains1.8 mg diclofenac free acid, equivalent to mg diclofenac potassium.
INDICATION OF CATAFLY SYRUP 140 ML
short-term treatment in the following acute conditions: – post-traumatic and post-operative pain, inflammation and swelling , eg . Following dental or orthopedic surgery . – as an adjuvantin severe painful inflammatory infections of the ear , nose or throat , eg. pharyngotosillitis , otitis . in keeping with general therapeutic priniciples , the underlying disease should be treated with basic therapy , as appropriate . fever alone is not an indication .
DOSAGE OF CATAFLY SYRUP 140 ML
Follow all directions given to you by your pharmacist or doctor carefully . They may differ from the information contained in this leaflet
Ask your pharmacist or doctor for help if you do not understand the instructions on the box .
The recommended dose is : –
as a general recommendation, the dose should be individually adjusted. Adverse effects may be minimized by using the lowest effective dose for the shortest duration necessary to control symptoms. – General target population : adults : specific pharmaceutical forms (eg. . tablets , suppositories , solusion for injection ) are available that are more suitable for use in adults .
the initial daily dose is 50 to 75 ml in milder cases , 37.5 to 50 ml daily is usually sufficient .
the total daily dose should generally be divided into 2 to 3 separate doses .
the maximum daily dose of 75 ml should not be exceeded .
– special populations :
– pediatric patients ( below 18 years of age ) : catafly oral suspension is particulary suitable for pediatric use , because they enable the dose to be adapted indoividually to the child’s body weight in accordance with the dosage schedule recommended for children .
children aged 1 year or over and adolescents should be given 0.25 to 1 ml/ kg body weight daily , depending on the severity of the disorder .
for adolescents aged 14 or over 3705 to 50 ml daily is usually sufficient . the total daily dose should generally be divided into 2 to 3 separate doses . the maximum daily dose of 75 ml should not be exceeded .
geriatric patients ( aged 65 years to above ) no adjustment of the starting dose is generally required for elderly patients. however, caution is indicated on no basic medical grounds, especially for frail elderly patients or those with a low body weight . –
established cardiovascular disease or significant cardiovascular risk factors :
treatment with catafly is generally not recommended in patients with established cardiovascular disease or uncontrolled hypertension or significant risk factors for cardiovascular disease should be treated with catafly only after careful consideration and only at doses <_ 100 mg ( i.e . 50 ml ) daily if treated for more thean 4 weeks .
– renal impairment : catafly is contraindicated in patients with renal failure ( GFR < 15 ml / min 1.73 m2 ) . no specific studies have been carried out in patients with renal impairment , therefore , no specific dose adustment recommendations can be made . caution is advised when administering catafly to patients with renal impairment .
– hepatic impairement : catafly is contraindicated in patients with hepatic failure . no specific studies have been caried out in patients with hepatic impairment , therefore , no specific dose adjustment recommendations can be made , caution is advised when administering catafly to patients with mild to moderate hepatic impairment .
– method of administration . the oral suspension should be swallowed , preferably before meals or on an empty stomach .
OVER-DOSAGE OF CATAFLY SYRUP 140 ML
there is no typical clinic picture resulting from diclofenac overdosage can cause symptoms such as vomiting , gastrointestinal hemorrage , diarrhea , dizziness, tinnitus ,or convullsions . In the event of significant poisoning , acute renal failure , and liver damage are possible .
CONTRA-INDICATION OF CATAFLY SYRUP 140 ML
known hypersensitivity to the active substance or to any of excipients.- active gastric or intestinal ulcer, bleeding or perforation – last trimester of pregnancy – hepatic failure – renal failure(GFR<15 ML / MIN/1.73M2) -sever cardiac failure. -like other non-steroidal anti-flammatory drugs (NSAIDs),catafly is also contraindicated in patients in whom attacks of asthma, urtrical, or acute rhinitis are precipitated by acetylsalicylic acid or other NDAIDs . – treatment of per-operative pain in the setting of coronary artery bypass graft(GABG) surgery.
STORAGE OF CATAFLY SYRUP 140 ML
it must be kept out of reach and sight of children .- it should not be used after the date marked “EXP” on the pack .
PACK OF CATAFLY SYRUP 140 ML
CATAFLY SYRUP 140 ML MANUFACTURED BY
Novartis Pharma AG , Basel, Switzerland